Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer

Clinical trial NCT00065429 · COMPLETED

Trial details

NCT number: NCT00065429
Sponsor: ImmunoGen, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2003-04-01
Primary completion: 2008-11-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.